Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized therapy for Strongyloides stercoralis infection: ivermectin vs thiabendazole
2004-004693-87Phase 3Completed
- Sponsor
- IRCCS Ospedale Sacro Cuore Don Calabria
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivermectin, Thiabendazole in strongyloidiasis, sponsored by IRCCS Ospedale Sacro Cuore Don Calabria. Started Jan 2005; status: completed.
02
Drugs
ivermectinThiabendazole
03
Conditions
strongyloidiasis
Beyond the preview
Go deeper on 2004-004693-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004693-87.